Log In
Print
BCIQ
Print
Print this Print this
 

RNActive influenza A vaccine

  Manage Alerts
Collapse Summary General Information
Company CureVac GmbH
DescriptionMRNA vaccine encoding the full-length influenza A virus hemagglutinin formulated using CureVac's RNActive technology
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityNucleic acid: Linear RNA
Latest Stage of DevelopmentPreclinical
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza A infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today